Gilead Q3 Product Sales Up 60% Due to HIV Drugs; Company Stops Development of Two Experimental HIV Drugs By khnweb Oct. 22, 2004
Largest HIV/AIDS Training Center in Sub-Saharan Africa Opens in Uganda; Institute Funded Largely by Pfizer By khnweb Oct. 21, 2004
Washington Post Examines Why Many HIV-Positive South Africans Prefer Traditional Therapies Over Antiretroviral Drugs By khnweb Oct. 21, 2004
High HIV Prevalence in Ecuadorian Province Could Lead To National Epidemic, U.N. Officials Say By khnweb Oct. 21, 2004
One-Quarter of Sexually Active NYC Public High School Students at High Risk for HIV, Other STDs, Study Says By khnweb Oct. 21, 2004
Neither Bush Nor Kerry Have Made International Development, Including AIDS Funding, Central Campaign Issue, Editorial Says By khnweb Oct. 21, 2004
Springfield, Mass., City Council Member Withdraws Measure Decriminalizing Needle Possession, Says He Will Refile By khnweb Oct. 21, 2004
HHS, Ad Council Launch National PSA Campaign Urging Young African-American Men To Be Tested for HIV By khnweb Oct. 20, 2004
Harvard School of Public Health Behind in Administering PEPFAR Grant for HIV/AIDS Treatment Programs By khnweb Oct. 20, 2004
Generic Drug Maker Ranbaxy To Resubmit Three AIDS Drugs Dropped From WHO Treatment List By khnweb Oct. 20, 2004
Seven European Countries Call for Increased Research Coordination in HIV/AIDS Vaccine Development By khnweb Oct. 20, 2004
Asia-Pacific Region Risks ‘AIDS Crisis’ Unless Governments, Regional Institutions ‘Step Up’ Efforts, UNAIDS Official Says By khnweb Oct. 20, 2004
Wilkes-Barre Times Leader Examines ‘Changing Face’ of HIV/AIDS Epidemic in Pennsylvania By khnweb Oct. 19, 2004
HIV/AIDS Epidemic Among African-American Women ‘Invisible’ to Politicians, Opinion Piece Says By khnweb Oct. 19, 2004
Arkansas Governor Will Not Use Discretionary Funding To Supplement ADAP Budget By khnweb Oct. 19, 2004